The Molecular Biology Section of the Translational Medicine Branch is recruiting a motivated postdoctoral candidate who has obtained a Ph.D. and/or M.D. within the past five years. Using in vitro, animal model, and human translational studies, we are focusing on novel mechanisms of mitochondrial regulation important for cell metabolism and cardiovascular function (Science, 312(5780):1650-3; Nature Medicine 7:1111-7). Of particular interest to our laboratory is the role of tumor suppressor p53 on energy and oxidant stress generation that significantly affects aerobic capacity, linked to both cancer and cardiovascular diseases.

The ideal candidate should have a strong molecular and basic research background demonstrated by first-author publications. Additional experience with transgenic mice, physiology, and metabolism will be advantageous. The successful candidate will be offered stipend commensurate with experience and supported with the excellent intramural resources and environment of the main NIH campus.

Interested applicants should click on the button below or submit their curriculum vitae, a statement of future research interests and career goals, along with the names and telephone numbers, postal, and e-mail addresses of three references to:

Paul M. Hwang, M.D., Ph.D.
Investigator
NHLBI-NIH
10 Center Drive, MSC 1454
Building 10-CRC, Room 5-5330
Bethesda, MD 20892-1670
E-mail: hwangp@mail.nih.gov


The NIH is dedicated to building a diverse community in its training and employment programs.

To apply:

The National Heart, Lung, and Blood Institute (NHLBI) provides leadership for a national program in diseases of the heart, blood vessels, lung, and blood; blood resources; and sleep disorders. Since October 1997, the NHLBI has also had administrative responsibility for the NIH Woman's Health Initiative.

The Institute plans, conducts, fosters, and supports an integrated and coordinated program of basic research, clinical investigations and trials, observational studies, and demonstration and education projects. Research is related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases; and sleep disorders. The NHLBI plans and directs research in development and evaluation of interventions and devices related to prevention, treatment, and rehabilitation of patients suffering from such diseases and disorders. It also supports research on clinical use of blood and all aspects of the management of blood resources. Research is conducted in the Institute's own laboratories and by scientific institutions and individuals supported by research grants and contracts.

For health professionals and the public, the NHLBI conducts educational activities, including development and dissemination of materials in the above areas, with an emphasis on prevention.

The NHLBI supports research training and career development of new and established researchers in fundamental sciences and clinical disciplines to enable them to conduct basic and clinical research related to heart, blood vessel, lung, and blood diseases; sleep disorders; and blood resources through individual and institutional research training awards and career development awards.

The Institute coordinates relevant activities in the above areas, including the related causes of stroke, with other research institutes and federal health programs. Relationships are maintained with institutions and professional associations, and with international, national, state, and local officials as well as voluntary agencies and organizations working in the above areas.